Search Results

Factors related to Post-traumatic Stress Disorder Symptoms among Intensive Care Unit Nurses.

• Authors : Kim SH; Department of Nursing, Graduate School, Kyung Hee University, SPACE 21 bldg., 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea 02447. Electronic address: .; Im Y

• Source: Asian nursing research [Asian Nurs Res (Korean Soc Nurs Sci)] 2024 May 02. Date of Electronic Publication: 2024 May 02.Publisher: Elsevier Country of Publication: Korea (South) NLM ID: 101321326 Publication Model: Print-Electronic Cited Medium:

Record details

Analyzing the effects of helical flow in blood vessels using acoustofluidic-based dynamic flow generator.

• Authors : Kwak D; Department of Mechanical Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.; Im Y

Subjects: Endothelial Cells* ; Atherosclerosis*; Humans

• Source: Acta biomaterialia [Acta Biomater] 2024 Mar 15; Vol. 177, pp. 216-227. Date of Electronic Publication: 2024 Jan 20.Publisher: Elsevier Country of Publication: England NLM ID: 101233144 Publication Model: Print-Electronic Cited Medium:

Record details

Outcomes of Intermittent Multidrug IV Therapy for Refractory Mycobacterium abscessus Pulmonary Disease.

• Authors : Im Y; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Kim SY

Subjects: Mycobacterium abscessus* ; Mycobacterium Infections, Nontuberculous*/Mycobacterium Infections, Nontuberculous*/Mycobacterium Infections, Nontuberculous*/diagnosis ; Mycobacterium Infections, Nontuberculous*/Mycobacterium Infections, Nontuberculous*/Mycobacterium Infections, Nontuberculous*/drug therapy

• Source: Chest [Chest] 2024 Feb; Vol. 165 (2), pp. 288-302. Date of Electronic Publication: 2023 Sep 03.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium:

Record details

A Comprehensive Overview of RNA Deconvolution Methods and Their Application.

• Authors : Im Y; School of Biological Sciences, Seoul National University, Seoul 08826, Korea.; Kim Y

Subjects: RNA* ; Transcriptome*; Tumor Microenvironment

• Source: Molecules and cells [Mol Cells] 2023 Feb 28; Vol. 46 (2), pp. 99-105.Publisher: Elsevier Country of Publication: United States NLM ID: 9610936 Publication Model: Print Cited Medium: Internet

Record details

Generation of integration-free induced pluripotent stem cell line (KSCBi017-A) from peripheral blood mononuclear cells of a healthy male individual.

• Authors : Sam Im Y; Division of Intractable Diseases Research, Korea National Institute of Health, Osong, Cheongju-si, South Korea.; Hoon Yoo D

Subjects: Induced Pluripotent Stem Cells*; Humans ; Male

• Source: Stem cell research [Stem Cell Res] 2022 Dec; Vol. 65, pp. 102965. Date of Electronic Publication: 2022 Nov 11.Publisher: Elsevier Country of Publication: England NLM ID: 101316957 Publication Model: Print-Electronic Cited Medium:

Record details

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study.

• Authors : Rugo HS; O'Shaughnessy J ...

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism ; Receptor, ErbB-2*/Receptor, ErbB-2*/Receptor, ErbB-2*/metabolism; Aminopyridines

• Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2022 Jun; Vol. 33 (6), pp. 616-627. Date of Electronic Publication: 2022 Mar 23.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium:

Record details

Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality.

• Authors : Im Y; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Hwang NY

Subjects: Lung Diseases*/Lung Diseases*/Lung Diseases*/diagnosis ; Lung Diseases*/Lung Diseases*/Lung Diseases*/drug therapy ; Lung Diseases*/Lung Diseases*/Lung Diseases*/microbiology

• Source: Chest [Chest] 2022 May; Vol. 161 (5), pp. 1192-1200. Date of Electronic Publication: 2021 Nov 16.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print-Electronic Cited Medium:

Record details

Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial.

• Authors : Dent S; The Ottawa Hospital Cancer Centre, Ottawa, Canada.; Cortés J

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Receptors, Estrogen*

• Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Feb; Vol. 32 (2), pp. 197-207. Date of Electronic Publication: 2020 Nov 10.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium:

Record details

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial.

• Authors : Litton JK; The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: .; Hurvitz SA

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/therapeutic use

• Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Nov; Vol. 31 (11), pp. 1526-1535. Date of Electronic Publication: 2020 Aug 20.Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium:

Record details

Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors.

• Authors : Im Y; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Lee J

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*adverse effects ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*complications ; Lung Neoplasms/Lung Neoplasms/Lung Neoplasms/*drug therapy

• Source: Respiratory medicine [Respir Med] 2020 Jan; Vol. 161, pp. 105853. Date of Electronic Publication: 2019 Dec 14.Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium:

Record details